Bardia Farman-Ara

Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study

David Taïeb, F. Sébag, Karine Baumstarck et al. · Clinical Endocrinology · 2008 · 103 citations

Iodine Biokinetics and Radioiodine Exposure after Recombinant Human Thyrotropin-Assisted Remnant Ablation in Comparison with Thyroid Hormone Withdrawal

David Taïeb, F. Sébag, Bardia Farman-Ara et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 71 citations

Value of 123I/99mTc-sestamibi parathyroid scintigraphy with subtraction SPECT/CT in primary hyperparathyroidism for directing minimally invasive parathyroidectomy

Pauline Asseeva, Nunzia Cinzia Paladino, Carole Guérin et al. · The American Journal of Surgery · 2018 · 17 citations

Subtraction Spect/ct, Parathyroid Hormone, 123I/99mtc-sestamibi Parathyroid Scintigraphy +8

Radiation doses to cohabitants of patients undergoing radioiodine ablation for thyroid cancer

S. Gabriel, Bardia Farman-Ara, Marc Bourrelly et al. · Nuclear Medicine Communications · 2011 · 16 citations

Proportional anatomical stereotactic atlas for visual interpretation of brain SPET perfusion images

Pierre Véra, Bardia Farman-Ara, Jean-Louis Stiévenart et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1996 · 11 citations

Engineering, Neuroimaging Modality, Medical Imaging +12